An Integrated Intervention of Computerized Cognitive Training and Physical Exercise in Virtual Reality for People With Alzheimer's Disease (JDome)

NCT ID: NCT05402423

Last Updated: 2023-10-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2022-06-27

Study Completion Date

2023-06-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

JDOME is a randomized controlled trial to test the effectiveness of a computerized cognitive training with the Brainer web platform and aerobic training with the JDOME system vs. a computerized cognitive training with the Brainer web platform and aerobic training with a standard exercise bike in subjects with Alzheimer's Disease at early stage. The JDome BikeAround is a tool that take people with dementia on a virtual bicycle tour along the paths of memories. It combines an exercise bike, a dome-shaped projector and Google Street View technology.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

JDOME study is designed as a randomized controlled trial to test the effectiveness of a training that combines the JDome virtual reality system for aerobic exercise with computerized cognitive training via tablet. The Experimental Group (EG) will receive computerized cognitive training with the Brainer web platform and aerobic training with the JDOME system (a tool that combines an exercise bike, a dome-shaped projector and Google Street View technology).The Control Group (CG) will receive computerized cognitive training with the Brainer web platform and aerobic training with a standard exercise bike.

Assessment will be performed at the baseline (T0), at the end of intervention (after eight weeks -T1) and 12 weeks after the end of intervention (follow-up T2).

The primary aim is to assess the stabilization of the global cognition of people with mild-stage Alzheimer's disease at the Mini-Mental State Examination (MMSE) and at the Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog); The secondary aim is the analyses of the modification of the quality of life, mood, behavioral disturbances, and physical function in people with mild-stage Alzheimer's disease.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

JDome rehabilitation group

Patients will undergo cognitive training with Brainer web platform via tablet followed by aerobic exercise with the JDome System

Group Type EXPERIMENTAL

Computerized cognitive training plus aerobic exercise with the JDome System

Intervention Type DEVICE

Sixteen treatment sessions of 60 minutes will be conducted (2 training sessions per week, for 8 weeks).

Each session will involve the following activities:

* 30 minutes of computerized cognitive training with the Brainer web platform, a medical device that contains 78 exercises in the five cognitive areas involved in the degeneration process of dementia
* 30 minutes of aerobic training with the JDOME system,

control group

Patients will undergo cognitive training with Brainer web platform via tablet followed by aerobic exercise with standard exercise bike

Group Type ACTIVE_COMPARATOR

Computerized cognitive training plus aerobic exercise with standard exercise bike

Intervention Type DEVICE

Sixteen treatment sessions of 60 minutes will be conducted (2 training sessions per week, for 8 weeks).

Each session will involve the following activities:

* 30 minutes of computerized cognitive training with the Brainer web platform, a medical device that contains 78 exercises in the five cognitive areas involved in the degeneration process of dementia
* 30 minutes of aerobic training with standard exercise bike

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Computerized cognitive training plus aerobic exercise with the JDome System

Sixteen treatment sessions of 60 minutes will be conducted (2 training sessions per week, for 8 weeks).

Each session will involve the following activities:

* 30 minutes of computerized cognitive training with the Brainer web platform, a medical device that contains 78 exercises in the five cognitive areas involved in the degeneration process of dementia
* 30 minutes of aerobic training with the JDOME system,

Intervention Type DEVICE

Computerized cognitive training plus aerobic exercise with standard exercise bike

Sixteen treatment sessions of 60 minutes will be conducted (2 training sessions per week, for 8 weeks).

Each session will involve the following activities:

* 30 minutes of computerized cognitive training with the Brainer web platform, a medical device that contains 78 exercises in the five cognitive areas involved in the degeneration process of dementia
* 30 minutes of aerobic training with standard exercise bike

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 65 and over;
* Pre-existing diagnosis of Alzheimer's, in mild phase, according to the 2011 criteria of the National Institute on Aging-Alzheimer's Association (NIA-AA);
* Clinical Dementia Rating Scale CDR = 1;
* Mini Mental State Examination MMSE \> 19;
* Functional Ambulation Categories FAC ≥4;
* Tinetti scale ≥ 20;
* Presence of a contact family caregiver
* Reside at home

* Sensory deficits not compensated by the use of prostheses
* Psychological and behavioral disorders not compensated by drug treatment
* Medical contraindication to moderate intensity aerobic exercise
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondazione Cariverona, Italy

UNKNOWN

Sponsor Role collaborator

Istituto Nazionale di Ricovero e Cura per Anziani

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Giuseppe Pelliccioni, MD

Role: PRINCIPAL_INVESTIGATOR

IRCCS INRCA, Ancona, Italy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cognitive Disorders and Dementia (CDCD) -INRCA Hospital

Ancona, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Gambella E, Margaritini A, Benadduci M, Rossi L, D'Ascoli P, Riccardi GR, Pasquini S, Civerchia P, Pelliccioni G, Bevilacqua R, Maranesi E. An integrated intervention of computerized cognitive training and physical exercise in virtual reality for people with Alzheimer's disease: The jDome study protocol. Front Neurol. 2022 Aug 12;13:964454. doi: 10.3389/fneur.2022.964454. eCollection 2022.

Reference Type DERIVED
PMID: 36034306 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

INRCA_003_2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.